| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stomach Neoplasms | 49 | 2024 | 195 | 7.010 |
Why?
|
| Helicobacter pylori | 20 | 2024 | 109 | 2.910 |
Why?
|
| Helicobacter Infections | 15 | 2024 | 78 | 2.360 |
Why?
|
| Gene Expression Regulation, Neoplastic | 24 | 2023 | 807 | 1.400 |
Why?
|
| Apoptosis | 15 | 2022 | 1398 | 1.080 |
Why?
|
| MicroRNAs | 10 | 2022 | 426 | 1.050 |
Why?
|
| Colonoscopy | 4 | 2019 | 104 | 0.990 |
Why?
|
| Adenoma | 7 | 2013 | 89 | 0.990 |
Why?
|
| Colonic Neoplasms | 7 | 2011 | 186 | 0.980 |
Why?
|
| Adenocarcinoma | 7 | 2018 | 251 | 0.970 |
Why?
|
| Cell Line, Tumor | 38 | 2024 | 2231 | 0.970 |
Why?
|
| Peptide Hormones | 7 | 2020 | 20 | 0.940 |
Why?
|
| Colorectal Neoplasms | 12 | 2019 | 441 | 0.920 |
Why?
|
| Neoplasm Proteins | 7 | 2019 | 213 | 0.870 |
Why?
|
| Gastric Mucosa | 10 | 2023 | 51 | 0.870 |
Why?
|
| Carcinoma | 3 | 2024 | 96 | 0.730 |
Why?
|
| Humans | 84 | 2024 | 37093 | 0.680 |
Why?
|
| Cell Proliferation | 22 | 2022 | 1198 | 0.670 |
Why?
|
| Epithelial Cells | 10 | 2021 | 384 | 0.660 |
Why?
|
| Peptide Library | 1 | 2018 | 25 | 0.630 |
Why?
|
| Stomach | 5 | 2020 | 45 | 0.630 |
Why?
|
| Repressor Proteins | 4 | 2021 | 249 | 0.610 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 65 | 0.610 |
Why?
|
| Patient Compliance | 2 | 2019 | 212 | 0.590 |
Why?
|
| Peptide Fragments | 1 | 2018 | 308 | 0.540 |
Why?
|
| Endoscopy | 1 | 2014 | 14 | 0.490 |
Why?
|
| Appointments and Schedules | 1 | 2014 | 19 | 0.490 |
Why?
|
| Nuclear Proteins | 8 | 2023 | 307 | 0.480 |
Why?
|
| Histones | 3 | 2017 | 190 | 0.450 |
Why?
|
| Down-Regulation | 6 | 2021 | 435 | 0.420 |
Why?
|
| District of Columbia | 5 | 2014 | 71 | 0.420 |
Why?
|
| Crohn Disease | 4 | 2021 | 63 | 0.400 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2022 | 213 | 0.400 |
Why?
|
| Antigens, Bacterial | 7 | 2019 | 132 | 0.400 |
Why?
|
| DNA Methylation | 7 | 2014 | 325 | 0.390 |
Why?
|
| Aged | 22 | 2021 | 6741 | 0.390 |
Why?
|
| Female | 38 | 2021 | 20969 | 0.390 |
Why?
|
| Aged, 80 and over | 11 | 2018 | 2379 | 0.390 |
Why?
|
| Mitochondria | 2 | 2019 | 487 | 0.380 |
Why?
|
| Antineoplastic Agents | 5 | 2020 | 803 | 0.380 |
Why?
|
| Precancerous Conditions | 2 | 2023 | 82 | 0.370 |
Why?
|
| Proteomics | 6 | 2021 | 325 | 0.370 |
Why?
|
| Male | 35 | 2021 | 20025 | 0.360 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 352 | 0.360 |
Why?
|
| Esophageal Neoplasms | 1 | 2011 | 127 | 0.360 |
Why?
|
| Homeodomain Proteins | 3 | 2019 | 132 | 0.350 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 178 | 0.350 |
Why?
|
| Tumor Cells, Cultured | 6 | 2020 | 502 | 0.350 |
Why?
|
| Autophagy | 3 | 2022 | 116 | 0.340 |
Why?
|
| Carcinoma in Situ | 1 | 2009 | 12 | 0.340 |
Why?
|
| alpha-Defensins | 2 | 2021 | 17 | 0.340 |
Why?
|
| Middle Aged | 24 | 2019 | 10129 | 0.340 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2008 | 7 | 0.330 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2021 | 75 | 0.330 |
Why?
|
| Transcription Factors | 4 | 2023 | 681 | 0.330 |
Why?
|
| Retrospective Studies | 7 | 2021 | 2026 | 0.330 |
Why?
|
| Mice | 17 | 2024 | 5913 | 0.320 |
Why?
|
| Histone Deacetylases | 1 | 2008 | 56 | 0.320 |
Why?
|
| Carrier Proteins | 6 | 2019 | 305 | 0.310 |
Why?
|
| Lysosomes | 2 | 2019 | 91 | 0.310 |
Why?
|
| Bacterial Proteins | 7 | 2019 | 540 | 0.300 |
Why?
|
| Transcription Factor AP-1 | 1 | 2007 | 35 | 0.300 |
Why?
|
| Colonic Polyps | 3 | 2014 | 67 | 0.290 |
Why?
|
| Microsatellite Instability | 5 | 2011 | 43 | 0.280 |
Why?
|
| Animals | 22 | 2024 | 15081 | 0.280 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2018 | 190 | 0.270 |
Why?
|
| Mutation | 4 | 2023 | 1095 | 0.270 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2022 | 194 | 0.270 |
Why?
|
| Lymphatic Metastasis | 3 | 2021 | 65 | 0.270 |
Why?
|
| Colon | 2 | 2021 | 103 | 0.260 |
Why?
|
| Fluorouracil | 1 | 2005 | 34 | 0.260 |
Why?
|
| Gene Expression Profiling | 7 | 2021 | 626 | 0.260 |
Why?
|
| Aspirin | 1 | 2005 | 49 | 0.250 |
Why?
|
| Cell Movement | 8 | 2021 | 571 | 0.250 |
Why?
|
| Neoplasm Staging | 6 | 2021 | 275 | 0.240 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2024 | 4 | 0.240 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2019 | 147 | 0.230 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2024 | 15 | 0.230 |
Why?
|
| Adenosine | 1 | 2024 | 59 | 0.230 |
Why?
|
| Ceramides | 1 | 2024 | 42 | 0.230 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2003 | 11 | 0.230 |
Why?
|
| Signal Transduction | 6 | 2019 | 1908 | 0.220 |
Why?
|
| Colitis, Ulcerative | 2 | 2021 | 54 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 5 | 2019 | 515 | 0.210 |
Why?
|
| Histone Deacetylase 1 | 2 | 2020 | 15 | 0.210 |
Why?
|
| Cell Line | 7 | 2021 | 1354 | 0.200 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2021 | 3 | 0.200 |
Why?
|
| Caspases | 1 | 2002 | 147 | 0.200 |
Why?
|
| Naphthalimides | 1 | 2021 | 3 | 0.200 |
Why?
|
| Immunohistochemistry | 6 | 2018 | 893 | 0.200 |
Why?
|
| Acetylation | 4 | 2020 | 98 | 0.200 |
Why?
|
| STAT3 Transcription Factor | 2 | 2019 | 90 | 0.200 |
Why?
|
| Benzimidazoles | 1 | 2021 | 36 | 0.200 |
Why?
|
| Mass Screening | 2 | 2019 | 462 | 0.200 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2020 | 43 | 0.200 |
Why?
|
| Exosomes | 2 | 2020 | 101 | 0.190 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2020 | 10 | 0.190 |
Why?
|
| Enterotoxins | 1 | 2021 | 33 | 0.190 |
Why?
|
| Organoids | 1 | 2021 | 22 | 0.190 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2020 | 12 | 0.190 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 28 | 0.190 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 59 | 0.190 |
Why?
|
| Hedgehog Proteins | 1 | 2021 | 50 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2020 | 259 | 0.180 |
Why?
|
| beta Catenin | 1 | 2020 | 48 | 0.180 |
Why?
|
| Disease Progression | 4 | 2021 | 601 | 0.180 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2020 | 9 | 0.180 |
Why?
|
| DNA-Binding Proteins | 3 | 2023 | 539 | 0.180 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2018 | 189 | 0.180 |
Why?
|
| Adult | 14 | 2018 | 11712 | 0.180 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 10 | 0.180 |
Why?
|
| Cannabidiol | 1 | 2019 | 5 | 0.180 |
Why?
|
| Up-Regulation | 4 | 2019 | 513 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 448 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 5 | 2020 | 661 | 0.180 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 37 | 0.170 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 92 | 0.170 |
Why?
|
| Iridoids | 1 | 2019 | 5 | 0.170 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2019 | 5 | 0.170 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2019 | 8 | 0.170 |
Why?
|
| Gastritis, Atrophic | 1 | 2019 | 10 | 0.170 |
Why?
|
| Cell Survival | 5 | 2019 | 864 | 0.170 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2019 | 12 | 0.170 |
Why?
|
| Outpatients | 2 | 2019 | 33 | 0.170 |
Why?
|
| Cholecalciferol | 1 | 2019 | 20 | 0.170 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 107 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 5 | 2019 | 251 | 0.160 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2009 | 24 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2017 | 92 | 0.160 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 433 | 0.160 |
Why?
|
| DNA Damage | 1 | 2020 | 352 | 0.160 |
Why?
|
| STAT Transcription Factors | 1 | 2017 | 12 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 54 | 0.150 |
Why?
|
| Janus Kinases | 1 | 2017 | 21 | 0.150 |
Why?
|
| Mice, Nude | 4 | 2020 | 337 | 0.150 |
Why?
|
| Cytoskeletal Proteins | 1 | 2018 | 105 | 0.150 |
Why?
|
| Hydrazines | 1 | 2016 | 21 | 0.140 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2016 | 11 | 0.140 |
Why?
|
| Phosphoproteins | 1 | 2018 | 163 | 0.140 |
Why?
|
| NF-kappa B | 3 | 2015 | 339 | 0.140 |
Why?
|
| Interferon-gamma | 1 | 2017 | 250 | 0.140 |
Why?
|
| Transfection | 4 | 2019 | 523 | 0.140 |
Why?
|
| Age Factors | 2 | 2009 | 1033 | 0.140 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 336 | 0.130 |
Why?
|
| Curcumin | 1 | 2016 | 74 | 0.130 |
Why?
|
| Receptors, Calcitriol | 2 | 2019 | 69 | 0.130 |
Why?
|
| Proteins | 2 | 2013 | 369 | 0.130 |
Why?
|
| Drug Therapy, Combination | 2 | 2006 | 227 | 0.130 |
Why?
|
| Gastrins | 1 | 2015 | 9 | 0.130 |
Why?
|
| Case-Control Studies | 6 | 2018 | 1130 | 0.130 |
Why?
|
| Microsatellite Repeats | 2 | 2005 | 59 | 0.120 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 42 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 98 | 0.120 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2014 | 4 | 0.120 |
Why?
|
| Gene Dosage | 1 | 2014 | 75 | 0.120 |
Why?
|
| CpG Islands | 1 | 2014 | 97 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 3 | 2021 | 169 | 0.120 |
Why?
|
| rho-Associated Kinases | 1 | 2014 | 31 | 0.120 |
Why?
|
| Hospitals | 1 | 2014 | 86 | 0.120 |
Why?
|
| Nod2 Signaling Adaptor Protein | 2 | 2012 | 6 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2012 | 628 | 0.110 |
Why?
|
| Risk Factors | 5 | 2014 | 3562 | 0.110 |
Why?
|
| Receptor, erbB-2 | 1 | 2014 | 133 | 0.110 |
Why?
|
| United States | 4 | 2022 | 4223 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2024 | 1207 | 0.110 |
Why?
|
| Homeostasis | 1 | 2014 | 188 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2012 | 30 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2012 | 767 | 0.110 |
Why?
|
| Gastroesophageal Reflux | 1 | 2012 | 31 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2012 | 859 | 0.110 |
Why?
|
| RNA, Small Interfering | 3 | 2023 | 409 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 2 | 2013 | 104 | 0.110 |
Why?
|
| Amino Acids | 1 | 2013 | 145 | 0.110 |
Why?
|
| Ribonucleoproteins | 1 | 2012 | 29 | 0.100 |
Why?
|
| PPAR gamma | 1 | 2012 | 53 | 0.100 |
Why?
|
| Quercetin | 1 | 2012 | 45 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1015 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2024 | 103 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 63 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 128 | 0.100 |
Why?
|
| Metaplasia | 2 | 2023 | 37 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 3 | 2019 | 173 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 1103 | 0.100 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2011 | 2 | 0.100 |
Why?
|
| Gene Fusion | 1 | 2011 | 6 | 0.100 |
Why?
|
| Butyrates | 1 | 2011 | 31 | 0.100 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 34 | 0.100 |
Why?
|
| Complement C9 | 1 | 2010 | 2 | 0.090 |
Why?
|
| Alpha-Globulins | 1 | 2010 | 4 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2016 | 938 | 0.090 |
Why?
|
| Oncogenes | 2 | 2020 | 43 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 61 | 0.090 |
Why?
|
| Cell Membrane | 2 | 2012 | 381 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 1067 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2024 | 174 | 0.090 |
Why?
|
| Biopsy | 3 | 2017 | 164 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 1609 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 295 | 0.090 |
Why?
|
| Chromosomal Instability | 2 | 2010 | 22 | 0.090 |
Why?
|
| Antibodies, Fungal | 1 | 2009 | 23 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2009 | 239 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 2 | 2024 | 186 | 0.090 |
Why?
|
| Rectum | 1 | 2009 | 22 | 0.090 |
Why?
|
| Cytokines | 1 | 2013 | 602 | 0.090 |
Why?
|
| Sex Factors | 2 | 2009 | 898 | 0.080 |
Why?
|
| Vitamin D | 1 | 2011 | 196 | 0.080 |
Why?
|
| Nuclear Envelope | 1 | 2008 | 9 | 0.080 |
Why?
|
| Cell Fractionation | 1 | 2008 | 30 | 0.080 |
Why?
|
| Proteome | 1 | 2010 | 144 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 2 | 2020 | 78 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2012 | 517 | 0.080 |
Why?
|
| Microarray Analysis | 1 | 2008 | 61 | 0.080 |
Why?
|
| ras Proteins | 1 | 2009 | 51 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 974 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2008 | 176 | 0.080 |
Why?
|
| Cell Cycle Proteins | 2 | 2023 | 229 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2020 | 325 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2008 | 143 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 206 | 0.080 |
Why?
|
| DNA Mismatch Repair | 1 | 2008 | 25 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2021 | 928 | 0.070 |
Why?
|
| Chi-Square Distribution | 3 | 2013 | 225 | 0.070 |
Why?
|
| Duodenal Ulcer | 1 | 2006 | 5 | 0.070 |
Why?
|
| Peptic Ulcer | 1 | 2006 | 9 | 0.070 |
Why?
|
| Penicillins | 1 | 2006 | 12 | 0.070 |
Why?
|
| Prevalence | 1 | 2011 | 1455 | 0.070 |
Why?
|
| Time Factors | 1 | 2011 | 1742 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 142 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 306 | 0.070 |
Why?
|
| Computational Biology | 2 | 2021 | 293 | 0.070 |
Why?
|
| Tissue Array Analysis | 2 | 2018 | 67 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2005 | 77 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2018 | 933 | 0.060 |
Why?
|
| Stomach Ulcer | 1 | 2004 | 5 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 172 | 0.060 |
Why?
|
| Gastritis | 1 | 2004 | 11 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 1371 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 152 | 0.060 |
Why?
|
| Herpesvirus 4, Human | 1 | 2024 | 33 | 0.060 |
Why?
|
| Gastric Mucins | 1 | 2023 | 3 | 0.060 |
Why?
|
| Virus Activation | 1 | 2024 | 35 | 0.060 |
Why?
|
| MutS Homolog 2 Protein | 3 | 2009 | 31 | 0.060 |
Why?
|
| Catalase | 1 | 2024 | 109 | 0.060 |
Why?
|
| RNA, Neoplasm | 2 | 2014 | 26 | 0.060 |
Why?
|
| Iran | 3 | 2009 | 190 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 219 | 0.060 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2022 | 4 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2016 | 461 | 0.050 |
Why?
|
| Peptide Termination Factors | 1 | 2022 | 3 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2013 | 108 | 0.050 |
Why?
|
| Haplorhini | 1 | 2002 | 22 | 0.050 |
Why?
|
| Cell Cycle | 2 | 2015 | 326 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2002 | 30 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 37 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2002 | 32 | 0.050 |
Why?
|
| Isotope Labeling | 2 | 2013 | 26 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1039 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2003 | 101 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2002 | 78 | 0.050 |
Why?
|
| Genomics | 1 | 2023 | 223 | 0.050 |
Why?
|
| Tennessee | 1 | 2022 | 70 | 0.050 |
Why?
|
| CDC2 Protein Kinase | 1 | 2021 | 17 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2002 | 207 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2021 | 31 | 0.050 |
Why?
|
| Mucin-6 | 1 | 2021 | 7 | 0.050 |
Why?
|
| Helicobacter felis | 1 | 2021 | 2 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2002 | 444 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 103 | 0.050 |
Why?
|
| Phenotype | 1 | 2023 | 689 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2021 | 389 | 0.050 |
Why?
|
| Research Personnel | 1 | 2022 | 155 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 142 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2021 | 1518 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2021 | 90 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2013 | 260 | 0.050 |
Why?
|
| Pinocytosis | 1 | 2020 | 8 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2020 | 150 | 0.050 |
Why?
|
| Vulnerable Populations | 1 | 2022 | 140 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2020 | 37 | 0.040 |
Why?
|
| Integrins | 1 | 2020 | 51 | 0.040 |
Why?
|
| Protein Binding | 2 | 2014 | 972 | 0.040 |
Why?
|
| Cathartics | 1 | 2019 | 6 | 0.040 |
Why?
|
| Calcium | 2 | 2019 | 480 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 182 | 0.040 |
Why?
|
| Haplotypes | 2 | 2012 | 182 | 0.040 |
Why?
|
| Janus Kinase 2 | 1 | 2019 | 32 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 1378 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 45 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2019 | 38 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 84 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 219 | 0.040 |
Why?
|
| Acetylglucosaminidase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Cathelicidins | 1 | 2019 | 2 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2019 | 10 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2019 | 84 | 0.040 |
Why?
|
| Acid Phosphatase | 1 | 2019 | 21 | 0.040 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2019 | 8 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2019 | 75 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 1180 | 0.040 |
Why?
|
| Cell Death | 1 | 2020 | 267 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2018 | 57 | 0.040 |
Why?
|
| Oman | 2 | 2008 | 6 | 0.040 |
Why?
|
| Incidence | 2 | 2013 | 922 | 0.040 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2019 | 35 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 93 | 0.040 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Clathrin | 1 | 2018 | 21 | 0.040 |
Why?
|
| Universities | 1 | 2022 | 442 | 0.040 |
Why?
|
| Azepines | 1 | 2018 | 17 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 148 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2018 | 37 | 0.040 |
Why?
|
| Models, Biological | 1 | 2021 | 677 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 923 | 0.040 |
Why?
|
| GTP-Binding Proteins | 2 | 2012 | 60 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 20 | 0.040 |
Why?
|
| Nucleosomes | 1 | 2017 | 29 | 0.040 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2017 | 19 | 0.040 |
Why?
|
| Muramidase | 1 | 2017 | 22 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 106 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 132 | 0.040 |
Why?
|
| Triazoles | 1 | 2018 | 86 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2017 | 130 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 409 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 187 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 217 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 146 | 0.040 |
Why?
|
| Protein Transport | 1 | 2018 | 302 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 364 | 0.040 |
Why?
|
| Cobalt | 1 | 2016 | 26 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2016 | 91 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 131 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 159 | 0.040 |
Why?
|
| Solubility | 1 | 2016 | 118 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 122 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2017 | 133 | 0.030 |
Why?
|
| Genotype | 2 | 2012 | 730 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 290 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 190 | 0.030 |
Why?
|
| Mucins | 2 | 2008 | 35 | 0.030 |
Why?
|
| Receptor, Cholecystokinin B | 1 | 2015 | 9 | 0.030 |
Why?
|
| Receptors, Growth Factor | 1 | 2015 | 12 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 808 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 41 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2014 | 41 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2005 | 31 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2014 | 16 | 0.030 |
Why?
|
| Adolescent | 3 | 2012 | 5363 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 64 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2013 | 79 | 0.030 |
Why?
|
| Proprotein Convertases | 1 | 2013 | 8 | 0.030 |
Why?
|
| Mannose-Binding Lectins | 1 | 2013 | 14 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2013 | 38 | 0.030 |
Why?
|
| Isoelectric Focusing | 1 | 2012 | 15 | 0.030 |
Why?
|
| Gastroscopy | 1 | 2012 | 7 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 201 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2013 | 149 | 0.030 |
Why?
|
| Anilides | 1 | 2012 | 28 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1618 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 95 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 2012 | 11 | 0.030 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2012 | 14 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2012 | 177 | 0.030 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2011 | 9 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 739 | 0.020 |
Why?
|
| Seasons | 1 | 2011 | 112 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 53 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 421 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 550 | 0.020 |
Why?
|
| Densitometry | 1 | 2010 | 13 | 0.020 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2011 | 38 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2010 | 50 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 90 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2010 | 66 | 0.020 |
Why?
|
| ROC Curve | 1 | 2010 | 138 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2010 | 69 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 3483 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 997 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 534 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2010 | 35 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2011 | 230 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 623 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Genes, APC | 1 | 2009 | 14 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 48 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2008 | 100 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 562 | 0.020 |
Why?
|
| Alleles | 1 | 2008 | 321 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 935 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 583 | 0.020 |
Why?
|
| Aging | 1 | 2011 | 664 | 0.020 |
Why?
|
| DNA Primers | 1 | 2005 | 286 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 448 | 0.010 |
Why?
|
| Phospholipases A | 1 | 2003 | 10 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2003 | 21 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2003 | 46 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 2003 | 90 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 307 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 587 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 4268 | 0.010 |
Why?
|